ChemoCentryx, Inc.
C5aR antagonists

Last updated:

Abstract:

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.

Status:
Grant
Type:

Utility

Filling date:

9 Jul 2018

Issue date:

26 May 2020